Revere Pharmaceuticals
PrivateLast Round
M&A
Feb 22, 2021
Total Funding Raised
$3.45M
Momentum Score
25 /100
Company Overview
Revere Pharmaceuticals is a biotechnology company developing small molecule therapeutics targeting Rho GTPase proteins for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revere Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Revere Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Feb 22, 2021 | ||||
| Seed | Jun 22, 2020 |
Revere Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XLerateHealth | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Monthly visitors grew 686% MoM, reaching 904.
Revere Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revere Pharmaceuticals's valuation, stock price, and market status.
